192 related articles for article (PubMed ID: 29281252)
1. Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons.
Henke A; Kovalyova Y; Dunn M; Dreier D; Gubernator NG; Dincheva I; Hwu C; Šebej P; Ansorge MS; Sulzer D; Sames D
ACS Chem Neurosci; 2018 May; 9(5):925-934. PubMed ID: 29281252
[TBL] [Abstract][Full Text] [Related]
2. Nonexocytotic serotonin release tonically suppresses serotonergic neuron activity.
Mlinar B; Montalbano A; Baccini G; Tatini F; Berlinguer Palmini R; Corradetti R
J Gen Physiol; 2015 Mar; 145(3):225-51. PubMed ID: 25712017
[TBL] [Abstract][Full Text] [Related]
3. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.
Narboux-Nême N; Sagné C; Doly S; Diaz SL; Martin CB; Angenard G; Martres MP; Giros B; Hamon M; Lanfumey L; Gaspar P; Mongeau R
Neuropsychopharmacology; 2011 Nov; 36(12):2538-50. PubMed ID: 21814181
[TBL] [Abstract][Full Text] [Related]
4. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
[TBL] [Abstract][Full Text] [Related]
5. APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter.
Karpowicz RJ; Dunn M; Sulzer D; Sames D
ACS Chem Neurosci; 2013 May; 4(5):858-69. PubMed ID: 23647019
[TBL] [Abstract][Full Text] [Related]
6. Activity-dependent vesicular monoamine transporter-mediated depletion of the nucleus supports somatic release by serotonin neurons.
Colgan LA; Putzier I; Levitan ES
J Neurosci; 2009 Dec; 29(50):15878-87. PubMed ID: 20016104
[TBL] [Abstract][Full Text] [Related]
7. Differential Uptake Mechanisms of Fluorescent Substrates into Stem-Cell-Derived Serotonergic Neurons.
Matthaeus F; Schloss P; Lau T
ACS Chem Neurosci; 2015 Dec; 6(12):1906-12. PubMed ID: 26503837
[TBL] [Abstract][Full Text] [Related]
8. Visualization of neurotransmitter uptake and release in serotonergic neurons.
Lau T; Proissl V; Ziegler J; Schloss P
J Neurosci Methods; 2015 Feb; 241():10-7. PubMed ID: 25528111
[TBL] [Abstract][Full Text] [Related]
9. Transitory uptake of serotonin in the developing sensory pathways of the common marmoset.
Lebrand C; Gaspar P; Nicolas D; Hornung JP
J Comp Neurol; 2006 Dec; 499(4):677-89. PubMed ID: 17029254
[TBL] [Abstract][Full Text] [Related]
10. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
[TBL] [Abstract][Full Text] [Related]
11. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration.
Alter SP; Stout KA; Lohr KM; Taylor TN; Shepherd KR; Wang M; Guillot TS; Miller GW
Exp Neurol; 2016 Jan; 275 Pt 1(Pt 1):17-24. PubMed ID: 26428905
[TBL] [Abstract][Full Text] [Related]
12. Axonal targeting of the serotonin transporter in cultured rat dorsal raphe neurons is specified by SEC24C-dependent export from the endoplasmic reticulum.
Montgomery TR; Steinkellner T; Sucic S; Koban F; Schüchner S; Ogris E; Sitte HH; Freissmuth M
J Neurosci; 2014 Apr; 34(18):6344-6351. PubMed ID: 24790205
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Biezonski DK; Meyer JS
J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
[TBL] [Abstract][Full Text] [Related]
14. Molecular Design of SERTlight: A Fluorescent Serotonin Probe for Neuronal Labeling in the Brain.
Lee WL; Westergaard X; Hwu C; Hwu J; Fiala T; Lacefield C; Boltaev U; Mendieta AM; Lin L; Sonders MS; Brown KR; He K; Asher WB; Javitch JA; Sulzer D; Sames D
J Am Chem Soc; 2024 Apr; 146(14):9564-9574. PubMed ID: 38557024
[TBL] [Abstract][Full Text] [Related]
15. Distinct contribution of axonal and somatodendritic serotonin transporters in drosophila olfaction.
Kasture AS; Bartel D; Steinkellner T; Sucic S; Hummel T; Freissmuth M
Neuropharmacology; 2019 Dec; 161():107564. PubMed ID: 30851308
[TBL] [Abstract][Full Text] [Related]
16. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
[TBL] [Abstract][Full Text] [Related]
17. A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function.
Vuorenpää A; Ammendrup-Johnsen I; Jørgensen TN; Gether U
Neurochem Int; 2016 Sep; 98():103-14. PubMed ID: 27020406
[TBL] [Abstract][Full Text] [Related]
18. Serotonin and molecular neuroimaging in humans using PET.
Saulin A; Savli M; Lanzenberger R
Amino Acids; 2012 Jun; 42(6):2039-57. PubMed ID: 21947614
[TBL] [Abstract][Full Text] [Related]
19. Methyl-4-phenylpyridinium (MPP+) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons.
Martí Y; Matthaeus F; Lau T; Schloss P
Mol Cell Neurosci; 2017 Sep; 83():37-45. PubMed ID: 28673772
[TBL] [Abstract][Full Text] [Related]
20. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.
Verney C; Lebrand C; Gaspar P
Anat Rec; 2002 Jun; 267(2):87-93. PubMed ID: 11997877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
